Veterinary Drugs Manufacturing
The National Veterinary Institute (NVI) was established in 1964 under the then the Ministry of Agriculture with the objective of producing different vaccines to protect animals from various infectious diseases. The institute again reorganized as a public enterprise in 1999 by the Council of ministers under the proclamation No 25/1992 and Regulations No. 52/1999 with the mandates of production of veterinary vaccines and drugs.
Accordingly, the Institute commenced the construction of a 100-million-birr worth GMP compliance veterinary drug manufacturing factory using its own budget in 2017 and has officially inaugurated on the 24th April 2021.
The inauguration ceremony was celebrated with the presence of senior government officials, invited guests, industry actors, stakeholders and the community of the institute. Getting the factory into operation through scaling up its rich experience in veterinary vaccines and moving towards manufacturing veterinary drugs demonstrates that the institute has become a national treasure thereby plays paramount role by ascertaining technology transfer and job creation.
With regard to its contribution for the national economy, the institute substitutes importation of veterinary vaccines and foreign currency earnings through exporting vaccines to different African countries. Being a public enterprise, it is an exemplary organization for self-reliance on its own budget with continuous expanding the facilities and creation of jobs for the youth.
In general, the Institute would like to take this opportunity to thank all the government and non-government organizations, stakeholders, beneficiaries, farmers and pastoralists, as well as the community at large, for their support that led towards the accomplishment of its mandates and beyond.
Public Relation Office of the National Veterinary Institute. (NVI-PR)